Androgen receptor trinucleotide polymorphism in endometriosis
letter
OA: closed
CC0
⤵ 26 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the association between androgen receptor trinucleotide repeat polymorphism and the risk of endometriosis in a specific population.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (4)
- Expression of size-polymorphic androgen receptor (AR) gene in ovarian endometriosis according to the number of cytosine, adenine, and guanine (CAG) repeats in AR alleles via openalex
- W1555159013 via openalex
- W1905194783 via openalex
- W1993761352 via openalex
Cited by (26)
- Androgens modulate endometrial function 2025
- Network pharmacology and experimental validation to explore the potential mechanism of Sanjie Zhentong Capsule in endometriosis treatment 2023
- Recent insights explaining susceptibility to endometriosis—From genetics to environment 2023
- Androgen Signaling in Uterine Diseases: New Insights and New Targets 2022
- Sex hormone-related polymorphisms in endometriosis and migraine: A narrative review 2022
- Endometriosis Research: From Bench to Bedside 2022
- Genetic Characterization of Endometriosis Patients: Review of the Literature and a Prospective Cohort Study on a Mediterranean Population 2020
- The Role of the Molecular Genetic Approach in the Pathogenesis of Endometriosis 2019
- Androgen receptor cytosine, adenine, and guanine trinucleotide repeat polymorphism in Korean patients with endometriosis: A case-control study 2017
- Integrative Analysis Reveals Regulatory Programs in Endometriosis 2015
- Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress 2012
- The effect of hormones on endometriosis development. 2011
- Polymorphic (CAG)n repeats in the androgen receptor gene 2009
- Functional genetic polymorphisms and female reproductive disorders: Part II--endometriosis 2008
- Genetic factors related to endometriosis: present and future 2007
- Endometriosis and Genetic Polymorphisms 2007
- Genetics of endometriosis: current status and prospects 2007
- Adenomyosis: the pathophysiology of an oestrogen-dependent disease 2006
- Estrogen receptor α-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma 2006
- Estrogen receptor α dinucleotide repeat and cytochrome P450c17α gene polymorphisms are associated with susceptibility to endometriosis 2005
- Association of Endometriosis Risk and Genetic Polymorphisms Involving Sex Steroid Biosynthesis and Their Receptors: A Meta-Analysis 2005
- Polymorphism for Transforming Growth Factor Beta 1-509 (TGF-B1-509): Association with Endometriosis 2005
- Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis 2005
- Biomarcadores de suscetibilidade à endometriose 2004
- Cytochrome P450c17α 5′-untranslated region *T/C polymorphism in endometriosis 2004
- Androgen Receptor Gene Cytosine, Adenine, and Guanine Trinucleotide Repeats in Patients With Endometriosis 2004
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:13:19.284922+00:00
License: CC0
· commercial use OK